AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update
The Readout Loud
Novartis's Acquisition of Morphosis and FDA Approval Challenges
The chapter delves into Novartis's acquisition of Morphosis and the challenges faced with FDA approval for the drug Pelabresib for myelofibrosis. It also discusses a pharmaceutical company's ambiguity in announcing FDA approval intentions for a new drug, leading to uncertainty and concerns.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode